Bioequivalence to become compulsory for generic drugs

Published: 2010-03-02 06:58:00

Updated: 2010-03-02 06:58:00

From this year, all generic drugs produced in Korea must prove they are equivalent to the patented medicines on which they are modeled, the Korea Food and Drug Administration said.

Generic drugs would be obliged to test for bioequivalence prior to entering the market. If any manufacturers are ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK